ReviewInflammatory bowel diseases2016

How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease.

Parambir S Dulai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.